Catapult Group International Ltd

CAT Details

Catapult Group International Ltd (ASX:CAT) has entered into an agreement to acquire the SportsMed Elite and Baseline athlete management system (AMS) products from Brisbane based SMG Technologies Pty Ltd (SMG) for $1.9mn. AMS products acquired SportsMed Elite is a leading SaaS product with an existing global user base of elite sporting clubs and associations. The modularized cloud-based platform acts as a store of team data and information, including player wellness metrics, injury and medical records, wearable data, and video. Permission based access enables coaches and staff to run analytics and output reports across data sets covering their entire playing group, and securely manage team calendars and player communication from within the platform. By bringing together coaching, strength and conditioning and medical data, the platform delivers an analytics layer that helps elite organizations make better and more informed decisions. Baseline is a team AMS solution specifically designed for the sub-elite market, with a simplified set of features delivering intuitive functionality and insights specifically for schools and semi-professional sporting groups. Both products have an existing global customer base, and while there is some minimal overlap with Catapult’s existing client list, the Transaction delivers a compelling cross-sell opportunity. Given the prospects, we give a “Buy” recommendation on the stock at the current market price of $1.90

Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.